Taking ageing into account in remyelination-based therapies for multiple sclerosis

Journal of the Neurological Sciences

Volumn 274, Issue 1-2, 2008, Pages 64-67

  Rist, Julia M ^a   Franklin, Robin J M ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Ageing; Multiple sclerosis; Precursor cell; Remyelination; Stem cell; Therapy

Indexed keywords

ADULT STEM CELL; AGE; AGING; ARTICLE; CELL FUNCTION; DEMYELINATION; DISEASE MODEL; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; REGENERATION; REMYELINIZATION; STEM CELL;

AGING; ANIMALS; CENTRAL NERVOUS SYSTEM; HUMANS; MULTIPLE SCLEROSIS; NERVE REGENERATION;

EID: 53049109182     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2008.04.027     Document Type: Article

References (52)

1. Franklin R.J.M., Gilson J.M., and Blakemore W.F. Local recruitment of remyelinating cells in the repair of demyelination in the central nervous system. J Neurosci Res 50 2 (1997) 337-344
2. Sim F.J., Zhao C., Penderis J., and Franklin R.J.M. The age-related decrease in CNS remyelination efficiency is attributable to an impairment of both oligodendrocyte progenitor recruitment and differentiation. J Neurosci 22 7 (2002) 2451-2459
3. Carroll W.M., and Jennings A.R. Early recruitment of oligodendrocyte precursors in CNS demyelination. Brain 117 Pt 3 (1994) 563-578
4. Bunge M.B., Bunge R.P., and Ris H. Ultrastructural study of remyelination in an experimental lesion in adult cat spinal cord. J Biophys Biochem Cytol 10 (1961) 67-94
5. Miller D.J., Asakura K., and Rodriguez M. Central nervous system remyelination clinical application of basic neuroscience principles. Brain Pathol 6 3 (1996) 331-344
6. Woodruff R.H., and Franklin R.J.M. Demyelination and remyelination of the caudal cerebellar peduncle of adult rats following stereotaxic injections of lysolecithin, ethidium bromide, and complement/anti-galactocerebroside: a comparative study. Glia 25 3 (1999) 216-228
7. Blakemore W.F. Remyelination of the superior cerebellar peduncle in the mouse following demyelination induced by feeding cuprizone. J Neurol Sci 20 1 (1973) 73-83
8. Prineas J.W., Barnard R.O., Kwon E.E., Sharer L.R., and Cho E.S. Multiple sclerosis: remyelination of nascent lesions. Ann Neurol 33 2 (1993) 137-151
9. Lassmann H., Bruck W., Lucchinetti C., and Rodriguez M. Remyelination in multiple sclerosis. Mult Scler 3 2 (1997) 133-136
10. Raine C.S., and Wu E. Multiple sclerosis: remyelination in acute lesions. J Neuropathol Exp Neurol 52 3 (1993) 199-204
11. Jeffery N.D., and Blakemore W.F. Locomotor deficits induced by experimental spinal cord demyelination are abolished by spontaneous remyelination. Brain 120 Pt 1 (1997) 27-37
12. Smith E.J., Blakemore W.F., and McDonald W.I. Central remyelination restores secure conduction. Nature 280 5721 (1979) 395-396
13. Kornek B., Storch M.K., Weissert R., Wallstroem E., Stefferl A., Olsson T., et al. Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions. Am J Pathol 157 1 (2000) 267-276
14. Patrikios P., Stadelmann C., Kutzelnigg A., Rauschka H., Schmidbauer M., Laursen H., et al. Remyelination is extensive in a subset of multiple sclerosis patients. Brain 129 Pt 12 (2006) 3165-3172
15. Ho A.D., Wagner W., and Mahlknecht U. Stem cells and ageing. The potential of stem cells to overcome age-related deteriorations of the body in regenerative medicine. EMBO Rep (2005) S35-S38 6 Spec No
16. Clark W., A Means to an End: The Biological Basis of Aging and Death. Oxford University Press, 1999. New York, NY, USA.
17. Hayflick L. How and Why We Age. Ballantine Books 1994: New York, NY, USA.
18. Davenport R.J. Regenerating regeneration. Sci Aging Knowledge Environ 35 (2004) ns6
19. Rando T.A. Stem cells, ageing and the quest for immortality. Nature 441 7097 (2006) 1080-1086
20. Lombard D.B., Chua K.F., Mostoslavsky R., Franco S., Gostissa M., and Alt F.W. DNA repair, genome stability, and aging. Cell 120 4 (2005) 497-512
21. Park Y., and Gerson S.L. DNA repair defects in stem cell function and aging. Annu Rev Med 56 (2005) 495-508
22. Flores I., Benetti R., and Blasco M.A. Telomerase regulation and stem cell behaviour. Curr Opin Cell Biol 18 3 (2006) 254-260
23. Van Zant G., Scott-Micus K., Thompson B.P., Fleischman R.A., and Perkins S. Stem cell quiescence/activation is reversible by serial transplantation and is independent of stromal cell genotype in mouse aggregation chimeras. Exp Hematol 20 4 (1992) 470-475
24. Rossi D.J., Bryder D., Zahn J.M., Ahlenius H., Sonu R., Wagers A.J., et al. Cell intrinsic alterations underlie hematopoietic stem cell aging. Proc Natl Acad Sci U S A 102 26 (2005) 9194-9199
25. Charge S.B., and Rudnicki M.A. Cellular and molecular regulation of muscle regeneration. Physiol Rev 84 1 (2004) 209-238
26. Conboy I.M., and Rando T.A. Aging, stem cells and tissue regeneration: lessons from muscle. Cell Cycle 4 3 (2005) 407-410
27. Schultz E., and Lipton B.H. Skeletal muscle satellite cells: changes in proliferation potential as a function of age. Mech Ageing Dev 20 4 (1982) 377-383
28. Bockhold K.J., Rosenblatt J.D., and Partridge T.A. Aging normal and dystrophic mouse muscle: analysis of myogenicity in cultures of living single fibers. Muscle Nerve 21 2 (1998) 173-183
29. Carlson B.M., and Faulkner J.A. Muscle transplantation between young and old rats: age of host determines recovery. Am J Physiol 256 6 Pt 1 (1989) C1262-C1266
30. Conboy I.M., Conboy M.J., Wagers A.J., Girma E.R., Weissman I.L., and Rando T.A. Rejuvenation of aged progenitor cells by exposure to a young systemic environment. Nature 433 7027 (2005) 760-764
31. Snoeck H.W. Serum of youth?. Nat Biotechnol 23 4 (2005) 434-435
32. Bortoli S., Renault V., Eveno E., Auffray C., Butler-Browne G., and Pietu G. Gene expression profiling of human satellite cells during muscular aging using cDNA arrays. Gene 321 (2003) 145-154
33. Shields S.A., Gilson J.M., Blakemore W.F., and Franklin R.J.M. Remyelination occurs as extensively but more slowly in old rats compared to young rats following gliotoxin-induced CNS demyelination. Glia 28 1 (1999) 77-83
34. Franklin R.J.M., Zhao C., and Sim F.J. Ageing and CNS remyelination. Neuroreport 13 7 (2002) 923-928
35. Hinks G.L., and Franklin R.J.M. Delayed changes in growth factor gene expression during slow remyelination in the CNS of aged rats. Mol Cell Neurosci 16 5 (2000) 542-556
36. Zhao C., Li W.W., and Franklin R.J.M. Differences in the early inflammatory responses to toxin-induced demyelination are associated with the age-related decline in CNS remyelination. Neurobiol Aging 27 9 (2006) 1298-1307
37. Hinks G.L., and Franklin R.J.M. Distinctive patterns of PDGF-A, FGF-2, IGF-I, and TGF-beta1 gene expression during remyelination of experimentally-induced spinal cord demyelination. Mol Cell Neurosci 14 2 (1999) 153-168
38. Diemel L.T., Copelman C.A., and Cuzner M.L. Macrophages in CNS remyelination: friend or foe?. Neurochem Res 23 3 (1998) 341-347
39. Kotter M.R., Setzu A., Sim F.J., Van Rooijen N., and Franklin R.J.M. Macrophage depletion impairs oligodendrocyte remyelination following lysolecithin-induced demyelination. Glia 35 3 (2001) 204-212
40. Kotter M.R., Li W.W., Zhao C., and Franklin R.J.M. Myelin impairs CNS remyelination by inhibiting oligodendrocyte precursor cell differentiation. J Neurosci 26 1 (2006) 328-332
41. Shen S., Liu A., Li J., Wolubah C., and Casaccia-Bonnefil P. Epigenetic memory loss in aging oligodendrocytes in the corpus callosum. Neurobiol Aging 29 3 (2008) 452-463
42. Penderis J., Shields S.A., and Franklin R.J.M. Impaired remyelination and depletion of oligodendrocyte progenitors does not occur following repeated episodes of focal demyelination in the rat central nervous system. Brain 126 Pt 6 (2003) 1382-1391
43. Mason J.L., Toews A., Hostettler J.D., Morell P., Suzuki K., Goldman J.E., et al. Oligodendrocytes and progenitors become progressively depleted within chronically demyelinated lesions. Am J Pathol 164 5 (2004) 1673-1682
44. Woodruff R.H., Fruttiger M., Richardson W.D., and Franklin R.J.M. Platelet-derived growth factor regulates oligodendrocyte progenitor numbers in adult CNS and their response following CNS demyelination. Mol Cell Neurosci 25 2 (2004) 252-262
45. Wolswijk G. Chronic stage multiple sclerosis lesions contain a relatively quiescent population of oligodendrocyte precursor cells. J Neurosci 18 2 (1998) 601-609
46. Franklin R.J.M. Why does remyelination fail in multiple sclerosis?. Nat Rev Neurosci 3 9 (2002) 705-714
47. Engel U., and Wolswijk G. Oligodendrocyte-type-2 astrocyte (O-2A) progenitor cells derived from adult rat spinal cord: in vitro characteristics and response to PDGF, bFGF and NT-3. Glia 16 1 (1996) 16-26
48. Wren D., Wolswijk G., and Noble M. In vitro analysis of the origin and maintenance of O-2Aadult progenitor cells. J Cell Biol 116 1 (1992) 167-176
49. Wolswijk G., and Noble M. Identification of an adult-specific glial progenitor cell. Development 105 2 (1989) 387-400
50. Tang D.G., Tokumoto Y.M., and Raff M.C. Long-term culture of purified postnatal oligodendrocyte precursor cells. Evidence for an intrinsic maturation program that plays out over months. J Cell Biol 148 5 (2000) 971-984
51. Chari D.M., Crang A.J., and Blakemore W.F. Decline in rate of colonization of oligodendrocyte progenitor cell (OPC)-depleted tissue by adult OPCs with age. J Neuropathol Exp Neurol 62 9 (2003) 908-916
52. Chari D.M., and Blakemore W.F. New insights into remyelination failure in multiple sclerosis: implications for glial cell transplantation. Mult Scler 8 4 (2002) 271-277